Cancer Biomarkers

Cancer biomarkers are used to detect the natural course of a tumour and are used to assess chances of developing cancer. Biomarkers in cancer screening play an important role in cancer detection and risk assessment to reduce cancer deaths. Tumour biomarkers are used to detect cancer development and progression. Uterine cervical cancer, endometrial cancer, trophoblastic neoplasms and ovarian cancer are gynaecologic malignancies for which tumour markers are in clinical use. Effective cancer biomarkers are used to reduce cancer mortality rates by facilitating diagnosis of cancers at early stages. Cancer biomarkers can also be used in diagnosis, risk assessment and recurrence of cancer.

    Related Conference of Cancer Biomarkers

    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 09-10, 2026

    4th World Congress on Oral Cancer

    Singapore City, Singapore
    March 30-31, 2026

    26th World Congress on Cancer and Diagnostics

    London, UK
    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in